SCHEMBL10489142

SCHEMBL10489142

CC(=O)C(C)(O)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16599779 0.79
Water SCHEMBL28435262 0.76 TSHR (0.41)
SCHEMBL3699750 0.72
SCHEMBL3689675 0.72 TSHR (0.53)
SCHEMBL14932100 0.71 CA4 (0.32)
SCHEMBL8645636 0.71
SCHEMBL61227 0.71
SCHEMBL1965420 0.71
SCHEMBL108620 0.71
SCHEMBL4932934 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118480154-A Synthesis method of quaternary amine acrylic ester active composite monomer grafted xylan/resveratrol lactobionic acid ester 桂林理工大学 2024-08-13 CN claimed
CN-118184886-A Synthesis method of stilbene triphenol and bagasse xylan composite esterified grafted high-fluorine derivative 桂林理工大学 2024-06-14 CN claimed
CN-118165185-A Method for synthesizing composite BX/Res biomass nano active material by using rectorite as catalyst 桂林理工大学 2024-06-11 CN claimed
CN-118480154-A Synthesis method of quaternary amine acrylic ester active composite monomer grafted xylan/resveratrol lactobionic acid ester 桂林理工大学 2024-08-13 CN disclosed
CN-118184886-A Synthesis method of stilbene triphenol and bagasse xylan composite esterified grafted high-fluorine derivative 桂林理工大学 2024-06-14 CN disclosed
CN-118165185-A Method for synthesizing composite BX/Res biomass nano active material by using rectorite as catalyst 桂林理工大学 2024-06-11 CN disclosed
US-RE32992-E THERAPY FOR INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS Fujisawa Pharaceutical Co., Ltd. (JP) 1989-07-18 US disclosed
US-4801580-A Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1989-01-31 US disclosed
US-4749691-A Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-07 US disclosed
US-4725582-A IMMUNE RESPONSE ENHANCERS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1988-02-16 US disclosed
EP-0025842-B1 PEPTIDES, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-03 EP disclosed
US-4539155-A New peptide, process for preparation thereof and use thereof FUISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1985-09-03 US disclosed
US-4504584-A PEPTIDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-03-12 US disclosed
US-4458078-A SYNTHESIS OF OLIGOPEPTIDES FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1984-07-03 US disclosed
US-4311640-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-01-19 US disclosed
EP-0025842-A2 Peptides, process for their preparation, their pharmaceutical compositions and their intermediates FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-04-01 EP disclosed